T-Cell Assay after COVID-19 Vaccination Could Be a Useful Tool? A Pilot Study on Interferon-Gamma Release Assay in Healthcare Workers

被引:8
作者
Seraceni, Silva [1 ]
Zocca, Elena [1 ]
Cervone, Tamara Emanuela [1 ]
Tomassetti, Flaminia [2 ,3 ]
Polidori, Isabella [3 ]
Valisi, Massimiliano [4 ]
Broccolo, Francesco [4 ,5 ]
Calugi, Graziella [3 ]
Bernardini, Sergio [2 ,6 ]
Pieri, Massimo [2 ,6 ]
机构
[1] Lifebrain RDI Srl, I-35010 Padua, Italy
[2] Univ Roma Tor Vergata, Dept Expt Med, I-00133 Rome, Italy
[3] Lifebrain Srl, I-00133 Rome, Italy
[4] Cerba HealthCare Italia, I-20139 Milan, Italy
[5] Univ Milano Bicocca, Dept Med & Surg, I-20900 Monza, Italy
[6] Tor Vergata Univ Hosp, Dept Lab Med, I-00100 Rome, Italy
关键词
adaptive responses; COVID-19; IGRA test; INF-gamma; T-cells; vaccination; SARS-COV-2;
D O I
10.3390/diseases10030049
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: SARS-CoV-2 T-cells are crucial for long-term protection against reinfection. The aim was to demonstrate the Interferon-gamma Release Assay (IGRA) test could be useful for vaccination monitoring. Methods: In a prospective cohort of 98 vaccinated healthcare workers for SARS-CoV-2, we selected 23 people in low-antibodies (Group 1, N = 8), high-antibodies (Group 2, N = 9), and negative control groups (Group 3, N = 6). SARS-CoV-2-specific humoral and cellular responses were analyzed at 8 months after two doses of Pfizer BioNTech, evaluating anti-RBD (Receptor Binding Domain) and RBD-ACE2 (Angiotensin Converting Enzyme-2) blocking antibodies in sera through a Chemiluminescence Immunoassay (CLIA) and T-cells through the IGRA test in heparinized plasma. Moreover, lymphocyte subtyping was executed by a flow cytometer. Statistical analysis was performed. Results: The data confirmed that RBD and RBD-ACE2 blocking ACE2 antibody levels of Group 1 were significantly lower than Group 2; p < 0.001. However, T-cells showed no significant difference between Group 1 and Group 2. Conclusions: This work suggests the need for new strategies for booster doses administration.
引用
收藏
页数:8
相关论文
共 20 条
[1]   Autoantibodies against type I IFNs in patients with life-threatening COVID-19 [J].
Bastard, Paul ;
Rosen, Lindsey B. ;
Zhang, Qian ;
Michailidis, Eleftherios ;
Hoffmann, Hans-Heinrich ;
Zhang, Yu ;
Dorgham, Karim ;
Philippot, Quentin ;
Rosain, Jeremie ;
Beziat, Vivien ;
Manry, Jeremy ;
Shaw, Elana ;
Haljasmagi, Liis ;
Peterson, Part ;
Lorenzo, Lazaro ;
Bizien, Lucy ;
Trouillet-Assant, Sophie ;
Dobbs, Kerry ;
de Jesus, Adriana Almeida ;
Belot, Alexandre ;
Kallaste, Anne ;
Catherinot, Emilie ;
Tandjaoui-Lambiotte, Yacine ;
Le Pen, Jeremie ;
Kerner, Gaspard ;
Bigio, Benedetta ;
Seeleuthner, Yoann ;
Yang, Rui ;
Bolze, Alexandre ;
Spaan, Andras N. ;
Delmonte, Ottavia M. ;
Abers, Michael S. ;
Aiuti, Alessandro ;
Casari, Giorgio ;
Lampasona, Vito ;
Piemonti, Lorenzo ;
Ciceri, Fabio ;
Bilguvar, Kaya ;
Lifton, Richard P. ;
Vasse, Marc ;
Smadja, David M. ;
Migaud, Melanie ;
Hadjadj, Jerome ;
Terrier, Benjamin ;
Duffy, Darragh ;
Quintana-Murci, Lluis ;
van de Beek, Diederik ;
Roussel, Lucie ;
Vinh, Donald C. ;
Tangye, Stuart G. .
SCIENCE, 2020, 370 (6515) :423-+
[2]   Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay [J].
Brand, Isabel ;
Gilberg, Leonard ;
Bruger, Jan ;
Gari, Merce ;
Wieser, Andreas ;
Eser, Tabea M. ;
Frese, Jonathan ;
Ahmed, Mohamed I. M. ;
Rubio-Acero, Raquel ;
Guggenbuehl Noller, Jessica M. ;
Castelletti, Noemi ;
Diekmannshemke, Jana ;
Thiesbrummel, Sophie ;
Huynh, Duc ;
Winter, Simon ;
Kroidl, Inge ;
Fuchs, Christiane ;
Hoelscher, Michael ;
Roider, Julia ;
Kobold, Sebastian ;
Pritsch, Michael ;
Geldmacher, Christof .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[4]   Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis [J].
Chen, Xinhua ;
Chen, Zhiyuan ;
Azman, Andrew S. ;
Sun, Ruijia ;
Lu, Wanying ;
Zheng, Nan ;
Zhou, Jiaxin ;
Wu, Qianhui ;
Deng, Xiaowei ;
Zhao, Zeyao ;
Chen, Xinghui ;
Ge, Shijia ;
Yang, Juan ;
Leung, Daniel T. ;
Yu, Hongjie .
CLINICAL INFECTIOUS DISEASES, 2022, 74 (04) :734-742
[5]   Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects [J].
Cristiano, Antonio ;
Nuccetelli, Marzia ;
Pieri, Massimo ;
Sarubbi, Serena ;
Pelagalli, Martina ;
Calugi, Graziella ;
Tomassetti, Flaminia ;
Bernardini, Sergio .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 101
[6]   Clinical Performance of a Standardized Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Interferon-γ Release Assay for Simple Detection of T-Cell Responses After Infection or Vaccination [J].
Fernandez-Gonzalez, Marta ;
Agullo, Vanesa ;
Padilla, Sergio ;
Alberto Garcia, Jose ;
Garcia-Abellan, Javier ;
Botella, Angela ;
Mascarell, Paula ;
Ruiz-Garcia, Montserrat ;
Masia, Mar ;
Gutierrez, Felix .
CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) :E338-E346
[7]   The WHO International Standard for COVID-19 serological tests: towards harmonization of anti-spike assays [J].
Infantino, Maria ;
Pieri, Massimo ;
Nuccetelli, Marzia ;
Grossi, Valentina ;
Lari, Barbara ;
Tomassetti, Flaminia ;
Calugi, Graziella ;
Pancani, Silvia ;
Benucci, Maurizio ;
Casprini, Patrizia ;
Manfredi, Mariangela ;
Bernardini, Sergio .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 100
[8]   T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals [J].
Jordan, Stanley C. ;
Shin, Bong-Ha ;
Gadsden, Terry-Ann M. ;
Chu, Maggie ;
Petrosyan, Anna ;
Le, Catherine N. ;
Zabner, Rachel ;
Oft, Jillian ;
Pedraza, Isabel ;
Cheng, Susan ;
Vo, Ashley ;
Ammerman, Noriko ;
Plummer, Jasmine ;
Ge, Shili ;
Froch, Max ;
Berg, Anders ;
Toyoda, Mieko ;
Zhang, Ruan .
CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (11) :2554-2556
[9]   Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia [J].
Kamphuis, Elisabeth ;
Junt, Tobias ;
Waibler, Zoe ;
Forster, Reinhold ;
Kalinke, Ulrich .
BLOOD, 2006, 108 (10) :3253-3261
[10]   Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals [J].
Lozano-Ojalvo, Daniel ;
Camara, Carmen ;
Lopez-Granados, Eduardo ;
Nozal, Pilar ;
Del Pino-Molina, Lucia ;
Yadira Bravo-Gallego, Luz ;
Paz-Artal, Estela ;
Pion, Marjorie ;
Correa-Rocha, Rafael ;
Ortiz, Alberto ;
Lopez-Hoyos, Marcos ;
Erro Iribarren, Marta ;
Portoles, Jose ;
Pilar Rojo-Portoles, Maria ;
Ojeda, Gloria ;
Cervera, Isabel ;
Gonzalez-Perez, Maria ;
Bodega-Mayor, Irene ;
Montes-Casado, Maria ;
Portoles, Pilar ;
Perez-Olmeda, Mayte ;
Oteo, Jesus ;
Sanchez-Tarjuelo, Rodrigo ;
Pothula, Venu ;
Schwarz, Megan ;
Brahmachary, Manisha ;
Tan, Anthony Tanoto ;
Le Bert, Nina ;
Berin, Cecilia ;
Bertoletti, Antonio ;
Guccione, Ernesto ;
Ochando, Jordi .
CELL REPORTS, 2021, 36 (08)